reviewPhysiological ReviewsJan 1, 2011Closed access

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

La Jolla Institute for Immunology

PubMed
Indexed incrossrefpubmed

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease in which destruction or damaging of the beta-cells in the islets of Langerhans results in insulin deficiency and hyperglycemia. We only know for sure that autoimmunity is the predominant effector mechanism of T1D, but may not be its primary cause. T1D precipitates in genetically susceptible individuals, very likely as a result of an environmental trigger. Current genetic data point towards the following genes as susceptibility genes: HLA, insulin, PTPN22, IL2Ra, and CTLA4. Epidemiological and other studies suggest a triggering role for enteroviruses, while other microorganisms might provide protection. Efficacious prevention of T1D will require detection of…

Citation impact

1,011
total citations
FWCI
64.77
Percentile
100%
References
507
Citations per year

Authors

3

Topics & keywords

Keywords
  • Immunology
  • Type 1 diabetes
  • Autoimmunity
  • Human leukocyte antigen
  • PTPN22
  • Autoantibody
  • Medicine
  • Immune system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding